Catalyst Wire Dossier Catalyst Wire Dossier

ESAT6-CFP10 Allergen (recombinant)

ESAT6-CFP10 · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ESAT6-CFP10 Allergen (recombinant), covering 2018-04-12 to 2018-04-12. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen for Children [Phase 3]

See pricing